The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Nanocarrier-based systems for targeted and site specific therapeutic delivery
Open accessAbstract
Systemic drug delivery methods such as oral or parenteral administration of free drugs possess relatively low treatment efficiency and marked adverse side effects. The use of nanoparticles for drug delivery in most cases substantially enhances drug efficacy, improves pharmacokinetics and drug release and limits their side effects. However, further enhancement in drug efficacy and significant limitation of adverse side effects can be achieved by specific targeting of nanocarrier-based delivery systems especially in combination with local administration. The present review describes major advantages and limitations of organic and inorganic nanocarriers or living cell-based drug and nucleic acid delivery systems. Among these, different nanoparticles, supramolecular gels, therapeutic cells as living drug carriers etc. have emerged as a new frontier in modern medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hydrogels for Tissue Engineering
Lee, K. Y., & Mooney, D. J. (2001) · Chemical Reviews · doi:10.1021/cr000108x · Cited by 5,277
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Low Molecular Mass Gelators of Organic Liquids and the Properties of Their Gels
Terech, P., & Weiss, R. G. (1997) · Chemical Reviews · doi:10.1021/cr9700282 · Cited by 3,130
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Liposomal Formulations in Clinical Use: An Updated Review
Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9020012 · Cited by 2,156
Supramolecular gels: Functions and uses
Sangeetha, N. M., & Maitra, U. (2005) · Chemical Society Reviews · doi:10.1039/b417081b · Cited by 2,045
Water Gelation by Small Organic Molecules
Estroff, L. A., & Hamilton, A. D. (2004) · Chemical Reviews · doi:10.1021/cr0302049 · Cited by 2,034
Micellar Nanocarriers: Pharmaceutical Perspectives
Torchilin, V. P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9132-0 · Cited by 1,910
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
Du, X., Zhou, J., Shi, J., & Xu, B. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00299 · Cited by 1,861
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J.-W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,236
Metal- and Anion-Binding Supramolecular Gels
Piepenbrock, M.-O. M., Lloyd, G. O., Clarke, N., & Steed, J. W. (2010) · Chemical Reviews · doi:10.1021/cr9003067 · Cited by 1,199
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Acharya, S., & Sahoo, S. K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.10.008 · Cited by 1,112
Attia, M. F., Anton, N., Wallyn, J., Omran, Z., & Vandamme, T. F. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13098 · Cited by 1,085
Jayawarna, V., Ali, M., Jowitt, T. A., Miller, A. F., Saiani, A., Gough, J. E., & Ulijn, R. V. (2006) · Advanced Materials · doi:10.1002/adma.200501522 · Cited by 1,028
Polyethylenimine-based non-viral gene delivery systems
Lungwitz, U., Breunig, M., Blunk, T., & Göpferich, A. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.11.011 · Cited by 983
George, M., & Weiss, R. G. (2006) · Accounts of Chemical Research · doi:10.1021/ar0500923 · Cited by 891
Cancer nanomedicine: A review of recent success in drug delivery
Tran, S., DeGiovanni, P., Piel, B., & Rai, P. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0175-0 · Cited by 879
Applications of gold nanoparticles in cancer nanotechnology
Cai, W. (2008) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s3788 · Cited by 851
Mesoporous silica nanoparticles in target drug delivery system: A review
Bharti, C., Gulati, N., Nagaich, U., & Pal, A. (2015) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.160844 · Cited by 817
Yeh, M.-K., Chang, H.-I., & Cheng, M.-Y. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s26766 · Cited by 801
Supramolecular gelling agents: can they be designed?
Dastidar, P. (2008) · Chemical Society Reviews · doi:10.1039/b807346e · Cited by 791
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Beloqui, A., Solinís, M. Á., Rodríguez-Gascón, A., Almeida, A. J., & Préat, V. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 769
Noble metals in medicine: Latest advances
Medici, S., Peana, M., Nurchi, V. M., Lachowicz, J. I., Crisponi, G., & Zoroddu, M. A. (2014) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2014.08.002 · Cited by 755
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
Stephan, M. T., Moon, J. J., Um, S. H., Bershteyn, A., & Irvine, D. J. (2010) · Nature Medicine · doi:10.1038/nm.2198 · Cited by 750
Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems
Yoo, J., Park, C., Yi, G., Lee, D., & Koo, H. (2019) · Cancers · doi:10.3390/cancers11050640 · Cited by 726
Chen, A. M., Zhang, M., Wei, D., Stueber, D., Taratula, O., Minko, T., & He, H. (2009) · Small · doi:10.1002/smll.200900621 · Cited by 671
Self-citationEnhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
Tang, L., Zheng, Y., Melo, M. B., Mabardi, L., Castaño, A. P., Xie, Y.-Q., Li, N., Kudchodkar, S. B., Wong, H. C., Jeng, E. K., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4181 · Cited by 660
Current Trends in The Use of Liposomes for Tumor Targeting
Deshpande, P. P., Biswas, S., & Torchilin, V. P. (2013) · Nanomedicine · doi:10.2217/nnm.13.118 · Cited by 657
Antibody–drug conjugates: targeted drug delivery for cancer
Alley, S. C., Okeley, N. M., & Senter, P. D. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.06.170 · Cited by 656
Zylberberg, C., & Matosevic, S. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1177136 · Cited by 627
Nanostructured lipid carriers for site-specific drug delivery
Khosa, A., Reddi, S., & Saha, R. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.055 · Cited by 619
Anion-tuned supramolecular gels: a natural evolution from urea supramolecular chemistry
Steed, J. W. (2010) · Chemical Society Reviews · doi:10.1039/b926219a · Cited by 599
A Cellular Trojan Horse for Delivery of Therapeutic Nanoparticles into Tumors
Choi, M.-R., Stanton-Maxey, K. J., Stanley, J. K., Levin, C. S., Bardhan, R., Akin, D., Badve, S., Sturgis, J., Robinson, J. P., Bashir, R., et al. (2007) · Nano Letters · doi:10.1021/nl072209h · Cited by 584
Semi-wet peptide/protein array using supramolecular hydrogel
Kiyonaka, S., Sada, K., Yoshimura, I., Shinkai, S., Kato, N., & Hamachi, I. (2004) · Nature Materials · doi:10.1038/nmat1034 · Cited by 560
A Review of Clinical Translation of Inorganic Nanoparticles
Anselmo, A. C., & Mitragotri, S. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9780-2 · Cited by 509
PEG-PCL-based nanomedicines: A biodegradable drug delivery system and its application
Grossen, P., Witzigmann, D., Sieber, S., & Huwyler, J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.05.028 · Cited by 496
Cheng, W., Nie, J., Xu, L., Liang, C., Peng, Y., Liu, G., Wang, T., Mei, L., Huang, L., & Zeng, X. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b02457 · Cited by 461
Nakada, T., Sugihara, K., Jikoh, T., Abe, Y., & Agatsuma, T. (2019) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c18-00744 · Cited by 442
Receptor-targeted nanocarriers for therapeutic delivery to cancer
Yu, B., Tai, H. C., Xue, W., Lee, L. J., & Lee, R. J. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.521200 · Cited by 423
Taratula, O., Kuzmov, A., Shah, M., Garbuzenko, O. B., & Minko, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.018 · Cited by 416
Self-citationPassive and active targeting in cancer therapy by liposomes and lipid nanoparticles
Alavi, M., & Hamidi, M. (2019) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2018-0032 · Cited by 405
Gao, Y., Kuang, Y., Guo, Z.-F., Guo, Z., Krauss, I. J., & Xu, B. (2009) · Journal of the American Chemical Society · doi:10.1021/ja904411z · Cited by 403
A Supramolecular‐Hydrogel‐Encapsulated Hemin as an Artificial Enzyme to Mimic Peroxidase
Wang, Q., Yang, Z., Zhang, X., Xiao, X., Chang, C. K., & Xu, B. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700404 · Cited by 399
Microvesicles and exosomes: Opportunities for cell-derived membrane vesicles in drug delivery
van Dommelen, S. M., Vader, P., Lakhal, S., Kooijmans, S. A. A., van Solinge, W. W., Wood, M. J. A., & Schiffelers, R. M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.021 · Cited by 398
Nanocarriers for delivery of platinum anticancer drugs
Oberoi, H. S., Nukolova, N. V., Kabanov, A. V., & Bronich, T. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.014 · Cited by 396
Nanostructured Lipid Carriers (NLCs) for Drug Delivery and Targeting
Fang, C.-L., A. Al-Suwayeh, S., & Fang, J.-Y. (2013) · Recent Patents on Nanotechnology · doi:10.2174/187221013804484827 · Cited by 367
Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer
Saad, M., Garbuzenko, O. B., & Minko, T. (2008) · Nanomedicine · doi:10.2217/17435889.3.6.761 · Cited by 367
Self-citationTargeted drug delivery via folate receptors
Zhao, X., Li, H., & Lee, R. J. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.3.309 · Cited by 358
Nanotechnology approaches for inhalation treatment of lung diseases
Kuzmov, A., & Minko, T. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.024 · Cited by 352
Self-citationTumor-specific targeting of an anticancer drug delivery system by LHRH peptide
Dharap, S. S., Wang, Y., Chandna, P., Khandare, J. J., Qiu, B., Gunaseelan, S., Sinko, P. J., Stein, S., Farmanfarmaian, A., & Minko, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504274102 · Cited by 340
Self-citationTaratula, O., Garbuzenko, O. B., Kirkpatrick, P., Pandya, I., Savla, R., Pozharov, V. P., He, H., & Minko, T. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.06.019 · Cited by 328
Self-citationSilica Nanorattle–Doxorubicin-Anchored Mesenchymal Stem Cells for Tumor-Tropic Therapy
Li, L., Guan, Y., Liu, H., Hao, N., Liu, T., Meng, X., Fu, C., Li, Y., Qu, Q., Zhang, Y., et al. (2011) · ACS Nano · doi:10.1021/nn202399w · Cited by 327
Batrakova, E. V., Gendelman, H. E., & Kabanov, A. V. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.559457 · Cited by 323
Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer
Savla, R., Taratula, O., Garbuzenko, O., & Minko, T. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.015 · Cited by 314
Self-citationDocetaxel for treatment of solid tumours: a systematic review of clinical data
Montero, A., Fossella, F., Hortobagyi, G., & Valero, V. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70094-2 · Cited by 311
Erythrocyte‐Inspired Delivery Systems
Hu, C. J., Fang, R. H., & Zhang, L. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200138 · Cited by 308
Lipid-Based Drug Delivery Systems
Shrestha, H., Bala, R., & Arora, S. (2014) · Journal of Pharmaceutics · doi:10.1155/2014/801820 · Cited by 304
Liposomes: Clinical Applications and Potential for Image-Guided Drug Delivery
Lamichhane, N., Udayakumar, T., D’Souza, W., Simone II, C., Raghavan, S., Polf, J., & Mahmood, J. (2018) · Molecules · doi:10.3390/molecules23020288 · Cited by 303
Yan, X., Cook, T. R., Pollock, J. B., Wei, P., Zhang, Y., Yu, Y., Huang, F., & Stang, P. J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja412249k · Cited by 278
Enhancing cell therapies from the outside in: Cell surface engineering using synthetic nanomaterials
Stephan, M. T., & Irvine, D. J. (2011) · Nano Today · doi:10.1016/j.nantod.2011.04.001 · Cited by 266
A Review on Electroporation-Based Intracellular Delivery
Shi, J., Ma, Y., Zhu, J., Chen, Y., Sun, Y., Yao, Y., Yang, Z., & Xie, J. (2018) · Molecules · doi:10.3390/molecules23113044 · Cited by 261
Microvesicle-mediated RNA Molecule Delivery System Using Monocytes/Macrophages
Akao, Y., Iio, A., Itoh, T., Noguchi, S., Itoh, Y., Ohtsuki, Y., & Naoe, T. (2011) · Molecular Therapy · doi:10.1038/mt.2010.254 · Cited by 253
Patlolla, R. R., Chougule, M., Patel, A. R., Jackson, T., Tata, P. N. V., & Singh, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.006 · Cited by 250
Drug Delivery Systems: Past, Present, and Future
Mainardes, R., & Silva, L. (2004) · Current Drug Targets · doi:10.2174/1389450043345407 · Cited by 249
Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial
Meunier, F., Prentice, H. G., & Ringden, O. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/28.suppl_b.83 · Cited by 247
Wáng, Y. X. J., & Idée, J.-M. (2017) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims.2017.02.09 · Cited by 247
Taratula, O., Garbuzenko, O. B., Chen, A. M., & Minko, T. (2011) · Journal of Drug Targeting · doi:10.3109/1061186x.2011.622404 · Cited by 245
Self-citationHom, C., Lu, J., Liong, M., Luo, H., Li, Z., Zink, J. I., & Tamanoi, F. (2010) · Small · doi:10.1002/smll.200901966 · Cited by 239
Saad, M., Garbuzenko, O. B., Ber, E., Chandna, P., Khandare, J. J., Pozharov, V. P., & Minko, T. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.024 · Cited by 238
Self-citationLipidoid-Coated Iron Oxide Nanoparticles for Efficient DNA and siRNA delivery
Jiang, S., Eltoukhy, A. A., Love, K. T., Langer, R., & Anderson, D. G. (2013) · Nano Letters · doi:10.1021/nl304287a · Cited by 236
Introduction and overview of peptide and protein pegylation
(2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00020-0 · Cited by 235
Ray, S., Das, A. K., & Banerjee, A. (2007) · Chemistry of Materials · doi:10.1021/cm062672f · Cited by 235
Pan, L., Liu, J., He, Q., & Shi, J. (2014) · Advanced Materials · doi:10.1002/adma.201402752 · Cited by 233
Clinical potential of electroporation for gene therapy and DNA vaccine delivery
Lambricht, L., Lopes, A., Kos, S., Sersa, G., Préat, V., & Vandermeulen, G. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1121990 · Cited by 230
Khandare, J. J., Jayant, S., Singh, A., Chandna, P., Wang, Y., Vorsa, N., & Minko, T. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060240p · Cited by 226
Self-citationTesauro, D., Accardo, A., Diaferia, C., Milano, V., Guillon, J., Ronga, L., & Rossi, F. (2019) · Molecules · doi:10.3390/molecules24020351 · Cited by 225
Lipoplatin Formulation Review Article
Stathopoulos, G. P., & Boulikas, T. (2012) · Journal of Drug Delivery · doi:10.1155/2012/581363 · Cited by 224
d-Glucosamine-based supramolecular hydrogels to improve wound healing
Yang, Z., Liang, G., Ma, M., Abbah, A. S., Lu, W. W., & Xu, B. (2007) · Chem. Commun. · doi:10.1039/b616563j · Cited by 222
Cruz, E., & Kayser, V. (2019) · Biologics: Targets and Therapy · doi:10.2147/btt.s166310 · Cited by 221
Stem cell-based therapies for cancer treatment: separating hope from hype
Stuckey, D. W., & Shah, K. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3798 · Cited by 220
Mejia Oneto, J. M., Khan, I., Seebald, L., & Royzen, M. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00150 · Cited by 215
Albarqi, H. A., Wong, L. H., Schumann, C., Sabei, F. Y., Korzun, T., Li, X., Hansen, M. N., Dhagat, P., Moses, A. S., Taratula, O., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b06542 · Cited by 215
Self-citationSurface-Modified and Internally Cationic Polyamidoamine Dendrimers for Efficient siRNA Delivery
Patil, M. L., Zhang, M., Betigeri, S., Taratula, O., He, H., & Minko, T. (2008) · Bioconjugate Chemistry · doi:10.1021/bc8000722 · Cited by 213
Self-citationWang, Z., Qiao, R., Tang, N., Lu, Z., Wang, H., Zhang, Z., Xue, X., Huang, Z., Zhang, S., Zhang, G., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.037 · Cited by 212
Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles
Stephan, M. T., Stephan, S. B., Bak, P., Chen, J., & Irvine, D. J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.029 · Cited by 209
Wan, X., Beaudoin, J. J., Vinod, N., Min, Y., Makita, N., Bludau, H., Jordan, R., Wang, A., Sokolsky, M., & Kabanov, A. V. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.032 · Cited by 201
Induction of Cancer Cell Death by Self-assembling Nanostructures Incorporating a Cytotoxic Peptide
Standley, S. M., Toft, D. J., Cheng, H., Soukasene, S., Chen, J., Raja, S. M., Band, V., Band, H., Cryns, V. L., & Stupp, S. I. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3267 · Cited by 198
Nanostructured Lipid Carriers: Versatile Oral Delivery Vehicle
Poonia, N., Kharb, R., Lather, V., & Pandita, D. (2016) · Future Science OA · doi:10.4155/fsoa-2016-0030 · Cited by 194
Coordination polymer gels with important environmental and biological applications
Jung, J. H., Lee, J. H., Silverman, J. R., & John, G. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35407a · Cited by 192
Murciano, J.-C., Medinilla, S., Eslin, D., Atochina, E., Cines, D. B., & Muzykantov, V. R. (2003) · Nature Biotechnology · doi:10.1038/nbt846 · Cited by 190
Rehman, F. U., Shah, K. U., Shah, S. U., Khan, I. U., Khan, G. M., & Khan, A. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1218462 · Cited by 190
Garbuzenko, O. B., Saad, M., Pozharov, V. P., Reuhl, K. R., Mainelis, G., & Minko, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004604107 · Cited by 185
Self-citationSupramolecular catalysis and dynamic assemblies for medicine
Feng, Z., Zhang, T., Wang, H., & Xu, B. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00472a · Cited by 184
Targeted cancer therapy through antibody fragments-decorated nanomedicines
Alibakhshi, A., Abarghooi Kahaki, F., Ahangarzadeh, S., Yaghoobi, H., Yarian, F., Arezumand, R., Ranjbari, J., Mokhtarzadeh, A., & de la Guardia, M. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.10.036 · Cited by 181
Applications of carrier erythrocytes in delivery of biopharmaceuticals
Hamidi, M., Zarrin, A., Foroozesh, M., & Mohammadi-Samani, S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.032 · Cited by 175
Molecular Targeting of Drug Delivery Systems to Cancer
Minko, T., Dharap, S., Pakunlu, R., & Wang, Y. (2004) · Current Drug Targets · doi:10.2174/1389450043345443 · Cited by 175
Self-citationThe inhibition of tumor growth and metastasis by self-assembled nanofibers of taxol
Wang, H., Wei, J., Yang, C., Zhao, H., Li, D., Yin, Z., & Yang, Z. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.047 · Cited by 175
Shah, V., Taratula, O., Garbuzenko, O. B., Taratula, O. R., Rodriguez-Rodriguez, L., & Minko, T. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1536 · Cited by 173
Self-citationPeptide ligand-mediated targeted drug delivery of nanomedicines
Jiang, Z., Guan, J., Qian, J., & Zhan, C. (2019) · Biomaterials Science · doi:10.1039/c8bm01340c · Cited by 172
Nanotechnology approaches for personalized treatment of multidrug resistant cancers
Minko, T., Rodríguez-Rodríguez, L., & Pozharov, V. P. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.017 · Cited by 169
Self-citationGarbuzenko, O. B., Saad, M., Betigeri, S., Zhang, M., Vetcher, A. A., Soldatenkov, V. A., Reimer, D. C., Pozharov, V. P., & Minko, T. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9755-4 · Cited by 167
Self-citationNanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration
Gaba, B., Fazil, M., Ali, A., Baboota, S., Sahni, J. K., & Ali, J. (2014) · Drug Delivery · doi:10.3109/10717544.2014.898110 · Cited by 164
Polymer therapeutics and the EPR effect
Maeda, H. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1365878 · Cited by 164
Huang, X., Zhang, F., Wang, H., Niu, G., Choi, K. Y., Swierczewska, M., Zhang, G., Gao, H., Wang, Z., Zhu, L., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.032 · Cited by 163
Neural Stem Cell-Mediated Intratumoral Delivery of Gold Nanorods Improves Photothermal Therapy
Mooney, R., Roma, L., Zhao, D., Van Haute, D., Garcia, E., Kim, S. U., Annala, A. J., Aboody, K. S., & Berlin, J. M. (2014) · ACS Nano · doi:10.1021/nn505147w · Cited by 162
Waite, C. L., & Roth, C. M. (2012) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.v40.i1.20 · Cited by 162
Motulsky, A., Lafleur, M., Couffin, A., Hoarau, D., Boury, F., Benoît, J., & Leroux, J. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.04.004 · Cited by 162
Overview of Antibody Drug Delivery
Awwad, S., & Angkawinitwong, U. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030083 · Cited by 160
Frigerio, B., Bizzoni, C., Jansen, G., Leamon, C. P., Peters, G. J., Low, P. S., Matherly, L. H., & Figini, M. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1123-1 · Cited by 160
Zhang, Y., Zhang, B., Kuang, Y., Gao, Y., Shi, J., Zhang, X. X., & Xu, B. (2013) · Journal of the American Chemical Society · doi:10.1021/ja402490j · Cited by 159
Schnepp, Z., Gonzalez-McQuire, R., & Mann, S. (2006) · Advanced Materials · doi:10.1002/adma.200502545 · Cited by 156
Shen, M., Liu, T., Yu, T.-W., Kv, R., Chiang, W., Tsai, Y.-C., Chen, H., Lin, S., & Chiu, H. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.019 · Cited by 154
Ryu, C. H., Park, S., Park, S. A., Kim, S. M., Lim, J. Y., Jeong, C. H., Yoon, W., Oh, W., Sung, Y. C., & Jeun, S. (2011) · Human Gene Therapy · doi:10.1089/hum.2010.187 · Cited by 152
Taratula, O., Garbuzenko, O. B., Savla, R., et al. (2010) · Current Drug Delivery · doi:10.2174/156720111793663642 · Cited by 151
Self-citationSeo, S. H., Kim, K. S., Park, S. H., Suh, Y. S., Kim, S. J., Jeun, S.-S., & Sung, Y. C. (2011) · Gene Therapy · doi:10.1038/gt.2010.170 · Cited by 148
Rodriguez, M. A., Pytlík, R., Kozák, T., Chhanabhai, M., Gascoyne, R. D., Lu, B., Deitcher, S. R., & Winter, J. N. (2009) · Cancer · doi:10.1002/cncr.24359 · Cited by 145
Ding, M., Song, N., He, X., Li, J., Zhou, L., Tan, H. S., Fu, Q., & Gu, Q. (2013) · ACS Nano · doi:10.1021/nn4002769 · Cited by 143
Drug delivery with living cells
Fliervoet, L. A. L., & Mastrobattista, E. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.021 · Cited by 143
Engineering the Surface of Therapeutic “Living” Cells
Park, J., Andrade, B., Seo, Y., Kim, M., Zimmerman, S. C., & Kong, H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00157 · Cited by 143
Zinc‐Triggered Hydrogelation of a Self‐Assembling β‐Hairpin Peptide
Micklitsch, C. M., Knerr, P. J., Branco, M. C., Nagarkar, R. P., Pochan, D. J., & Schneider, J. P. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006652 · Cited by 141
Ooya, T., Lee, J., & Park, K. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049814l · Cited by 140
siRNA Delivery to the lung: What's new?
Merkel, O. M., Rubinstein, I., & Kissel, T. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.018 · Cited by 138
Supramolecular filaments containing a fixed 41% paclitaxel loading
Lin, R., Cheetham, A. G., Zhang, P., Lin, Y., & Cui, H. (2013) · Chemical Communications · doi:10.1039/c3cc41896k · Cited by 133
Liposomal daunorubicin as treatment for Kaposi’s sarcoma
Dittmer, D. P., & Petre, C. E. (2007) · PubMed Central · doi:10.17615/wyf0-9n94 · Cited by 130
Pegylated liposomal doxorubicin in ovarian cancer.
Green, A. E., & Rose, P. G. (2006) · PubMed Central · Cited by 128
Garbuzenko, O. B., Mainelis, G., Taratula, O., & Minko, T. (2014) · Europe PMC (PubMed Central) · doi:10.7497/j.issn.2095-3941.2014.01.004 · Cited by 121
Self-citationMao, L., Wang, H., Tan, M., Ou, L., Kong, D., & Yang, Z. (2011) · Chemical Communications · doi:10.1039/c1cc16250k · Cited by 120
Stem Cells Loaded with Nanoparticles as a Drug Carrier for In Vivo Breast Cancer Therapy
Cao, B., Yang, M., Zhu, Y., Qu, X., & Mao, C. (2014) · Advanced Materials · doi:10.1002/adma.201401550 · Cited by 117
Organic nanoparticles for drug delivery and imaging
Mitragotri, S., & Stayton, P. S. (2014) · MRS Bulletin · doi:10.1557/mrs.2014.11 · Cited by 114
Moody, T. W., Nuche‐Berenguer, B., & Jensen, R. T. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000218 · Cited by 112
Challenges in oral drug delivery: a nano-based strategy to overcome
Viswanathan, P., Muralidaran, Y., & Ragavan, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-47720-8.00008-0 · Cited by 111
Xu, G., Jiang, X., Xu, Y., Zhang, J., Huang, F., Chen, Z., Zhou, D., Shang, J., Zou, Y., Cai, Y., et al. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2008.07.023 · Cited by 109
Mendes, R. G. P. R., Fernandes, A. R., & Baptista, P. V. (2017) · Genes · doi:10.3390/genes8030094 · Cited by 109
A perspective on magnetic core–shell carriers for responsive and targeted drug delivery systems
Albinali, K. E., Zagho, M. M., Deng, Y., & Elzatahry, A. A. F. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s193981 · Cited by 108
In Vivo Targeting of Tumor Endothelial Cells by Systemic Delivery of Lentiviral Vectors
Palma, M. D., Venneri, M. A., & Naldini, L. (2003) · Human Gene Therapy · doi:10.1089/104303403322168028 · Cited by 106
Kirkpatrick, G. J., Plumb, J. A., Sutcliffe, O. B., Flint, D. J., & Wheate, N. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.05.017 · Cited by 105
Tam, A. Y., Wong, K. M., & Yam, V. W. (2009) · Chemistry - A European Journal · doi:10.1002/chem.200900046 · Cited by 103
Alizadeh, D., Zhang, L., Hwang, J., Schluep, T., & Badie, B. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.10.001 · Cited by 103
Xu, C., Jere, D., Jin, H., Chang, S.-H., Chung, Y.-S., Shin, J., Kim, J., Park, S. J., Lee, Y.-H., Chae, C., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1022oc · Cited by 102
Huang, X., Tao, Z., Praskavich, J. C., Goswami, A., Al‐Sharab, J. F., Minko, T., Polshettiwar, V., & Asefa, T. (2014) · Langmuir · doi:10.1021/la501435a · Cited by 102
Self-citationGarbuzenko, O. B., Winkler, J. S., Tomassone, M. S., et al. (2014) · Langmuir · doi:10.1021/la502144z · Cited by 101
New Generation of Liposomal Drugs for Cancer
Minko, T., Pakunlu, R. I., Wang, Y., Khandare, J. J., & Saad, M. (2006) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006778699095 · Cited by 99
Self-citationSurface Re-engineering of Pancreatic Islets with Recombinant azido-Thrombomodulin
Stabler, C. L., Sun, X., Cui, W., Wilson, J. T., Haller, C. A., & Chaikof, E. L. (2007) · Bioconjugate Chemistry · doi:10.1021/bc7002814 · Cited by 96
The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro
Wu, W. Y. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s8503 · Cited by 94
Tyrosine-based rivastigmine-loaded organogels in the treatment of Alzheimer’s disease
Bastiat, G., Plourde, F., Motulsky, A., Fürtös, A., Dumont, Y., Quirion, R., Fuhrmann, G., & Leroux, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.009 · Cited by 91
Functional polyesters enable selective siRNA delivery to lung cancer over matched normal cells
Yan, Y., Liu, L., Xiong, H., Miller, J. B., Zhou, K., Kós, P., Huffman, K. E., Elkassih, S. A., Norman, J. W., Carstens, R. M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606886113 · Cited by 90
Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2
Ivanova, V., Garbuzenko, O. B., Reuhl, K. R., Reimer, D. C., Pozharov, V. P., & Minko, T. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.11.023 · Cited by 88
Self-citationSingh, M. P., Kundu, S., Amarendar Reddy, M., Sreekanth, V., Motiani, R. K., Sengupta, S., Srivastava, A., & Bajaj, A. (2014) · Nanoscale · doi:10.1039/c4nr04064c · Cited by 87
Potential Use of Nanostructured Lipid Carriers for Topical Delivery of Flurbiprofen
González‐Mira, E., Nikolic, S., García, M. L., et al. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22271 · Cited by 87
An Update on Anti-CD137 Antibodies in Immunotherapies for Cancer
Chu, D., Bac, N., Nguyen, K. H., Tien, N. L. B., Thanh, V. V., Nga, V. T., Ngọc, V. T. N., Đào, D. T. A., Hoàn, L. N., Hung, N., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081822 · Cited by 85
Applications of Copolymeric Nanoparticles in Drug Delivery Systems
Danafar, H. (2016) · Drug Research · doi:10.1055/s-0042-109865 · Cited by 83
Li, X., Schumann, C., Albarqi, H. A., Lee, C. J., Alani, A. W. G., Bracha, S., Milovancev, M., Taratula, O. R., & Taratula, O. (2017) · Theranostics · doi:10.7150/thno.21209 · Cited by 83
Self-citationRichards, D. A. (2018) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2018.10.005 · Cited by 83
Deb, J., Majumder, J., Bhattacharyya, S., & Jana, S. S. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-567 · Cited by 82
Self-citationDembinski, J. L., Wilson, S. M., Spaeth, E. L., Studeny, M., Zompetta, C., Samudio, I. J., Roby, K. F., Andreeff, M., & Marini, F. C. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2012.10.003 · Cited by 81
Genotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids.
Shah, V., Taratula, O., Garbuzenko, O. B., Patil, M. L., Savla, R., Zhang, M., & Minko, T. (2013) · PubMed · Cited by 81
Self-citationShreya, A. B., Raut, S. Y., Managuli, R. S., Udupa, N., & Mutalik, S. (2018) · AAPS PharmSciTech · doi:10.1208/s12249-018-1262-2 · Cited by 80
Taratula, O. R., Doddapaneni, B. S., Schumann, C., Li, X., Bracha, S., Milovancev, M., Alani, A. W. G., & Taratula, O. (2015) · Chemistry of Materials · doi:10.1021/acs.chemmater.5b03128 · Cited by 77
Self-citationLHRH-Targeted Drug Delivery Systems for Cancer Therapy
Li, X., Taratula, O., Taratula, O. R., Schumann, C., & Minko, T. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666161013111155 · Cited by 77
Self-citationLuo, Y., Zhai, X., Ma, C., Sun, P., Fu, Z., Liu, W., & Xu, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.005 · Cited by 76
WT1 gene silencing by aerosol delivery of PEI–RNAi complexes inhibits B16-F10 lung metastases growth
Zamora-Ávila, D. E., Zapata‐Benavides, P., Franco-Molina, M. Á., Saavedra-Alonso, S., Trejo-Avila, L. M., Reséndez‐Pérez, D., Méndez-Vázquez, J. L., Isaias-Badillo, J., & Rodrı́guez-Padilla, C. (2009) · Cancer Gene Therapy · doi:10.1038/cgt.2009.35 · Cited by 75
Garbuzenko, O. B., Ivanova, V., Kholodovych, V., Reimer, D. C., Reuhl, K. R., Yurkow, E. J., Adler, D., & Minko, T. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.04.005 · Cited by 74
Self-citationGarbuzenko, O. B., Kbah, N., Kuzmov, A., Pogrebnyak, N., Pozharov, V. P., & Minko, T. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.025 · Cited by 73
Self-citationUsonis, V., Bakasénas, V., Valentelis, R., Katiliene, G., Vidzeniene, D., & Herzog, C. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00509-7 · Cited by 72
Bardal, S. K., Waechter, J. E., & Martin, D. S. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0310-8.00002-6 · Cited by 71
Gold Nanoparticle‐Loaded Neural Stem Cells for Photothermal Ablation of Cancer
Schnarr, K., Mooney, R., Weng, Y., Zhao, D., Garcia, E., Armstrong, B., Annala, A. J., Kim, S. U., Aboody, K. S., & Berlin, J. M. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300003 · Cited by 70
Yan, Y., Zhou, K., Xiong, H., Miller, J. B., Motea, E. A., Boothman, D. A., Liu, L., & Siegwart, D. J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.12.001 · Cited by 68
Cell-based drug delivery systems for biomedical applications
Li, T., Dong, H., Zhang, C., & Mo, R. (2018) · Nano Research · doi:10.1007/s12274-018-2179-5 · Cited by 68
MPEG–PCL copolymeric nanoparticles in drug delivery systems
Danafar, H. (2016) · Cogent Medicine · doi:10.1080/2331205x.2016.1142411 · Cited by 67
Conjugation of pH-responsive nanoparticles to neural stem cells improves intratumoral therapy
Mooney, R., Weng, Y., Garcia, E. P., Bhojane, S., Smith‐Powell, L., Kim, S. U., Annala, A. J., Aboody, K. S., & Berlin, J. M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.015 · Cited by 66
Labile Catalytic Packaging of DNA/siRNA: Control of Gold Nanoparticles “out” of DNA/siRNA Complexes
Chen, A. M., Taratula, O., Wei, D., Yen, H.-I., Thomas, T., Thomas, T., Minko, T., & He, H. (2010) · ACS Nano · doi:10.1021/nn901796n · Cited by 66
Self-citationTargeting Folate Receptors to Treat Invasive Urinary Bladder Cancer
Dhawan, D., Ramos‐Vara, J. A., Naughton, J. F., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2101 · Cited by 65
Majumder, J., Deb, J., Das, M., Jana, S. S., & Dastidar, P. (2013) · Chemical Communications · doi:10.1039/c3cc48513g · Cited by 64
Self-citationCo-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy
Han, Y., Zhang, P., Chen, Y., Sun, J., & Kong, F. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1770 · Cited by 62
Engineering biodegradable nanoparticles for drug and gene delivery.
Zhang, J., & Saltzman, W. M. (2013) · PubMed · Cited by 61
Mendes, L. P., Sarısözen, C., Luther, E., Pan, J., & Torchilin, V. P. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1574935 · Cited by 59
Ito, S., Natsume, A., Shimato, S., Ohno, M., Kato, T., Chansakul, P., Wakabayashi, T., & Kim, S. U. (2009) · Cancer Gene Therapy · doi:10.1038/cgt.2009.80 · Cited by 58
Supramolecular Synthon Approach in Designing Molecular Gels for Advanced Therapeutics
Dastidar, P., Roy, R., Parveen, R., & Sarkar, K. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800061 · Cited by 57
Murciano, J.-C., Higazi, A. A., Cines, D. B., et al. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.07.003 · Cited by 56
Zhang, M., Garbuzenko, O. B., Reuhl, K. R., Rodríguez-Rodríguez, L., & Minko, T. (2012) · Nanomedicine · doi:10.2217/nnm.11.131 · Cited by 52
Self-citationNanotechnology approaches for inhalation treatment of fibrosis
Savla, R., & Minko, T. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.829078 · Cited by 50
Self-citationTumor-Targeted Responsive Nanoparticle-Based Systems for Magnetic Resonance Imaging and Therapy
Savla, R., Garbuzenko, O. B., Chen, S., Rodríguez-Rodríguez, L., & Minko, T. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1436-x · Cited by 49
Self-citationLuft, C., & Ketteler, R. (2015) · SLAS DISCOVERY · doi:10.1177/1087057115579638 · Cited by 48
Pulmonary administration of small interfering RNA: The route to go?
Ruigrok, M. J. R., Frijlink, H. W., & Hinrichs, W. L. J. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.054 · Cited by 47
Nano Drug Delivery Systems to Overcome Cancer Drug Resistance - A Review
Koushik, O. S., & Rao, Y. V. (2016) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000378 · Cited by 47
Prevention of paclitaxel-induced neuropathy by formulation approach
Zang, X., Lee, J. B., Deshpande, K., Garbuzenko, O. B., Minko, T., & Kagan, L. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.013 · Cited by 47
Self-citationAdedoyin, A. B., Swenson, C. E., Bolcsak, L. E., Hellmann, A. R., Radowska, D., Horwith, G., Janoff, A. S., & Branch, R. A. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2900-2902.2000 · Cited by 46
Extended‐Release Epidural Morphine (DepoDur™): An Old Drug with a New Profile
Alam, M., & Hartrick, C. T. (2005) · Pain Practice · doi:10.1111/j.1533-2500.2005.00048.x · Cited by 45
Takeda, T., Inaba, H., Yamazaki, M., Kyo, S., Miyamoto, T., Suzuki, S., Ehara, T., Kakizawa, T., Hara, M., DeGroot, L. J., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021856 · Cited by 45
Xu, C., Tian, H., Wang, P., Wang, Y., & Chen, X. (2016) · Biomaterials Science · doi:10.1039/c6bm00601a · Cited by 45
Recent progress in nanomaterials for nucleic acid delivery in cancer immunotherapy
Mei, Y., Wang, R., Jiang, W., Yang, B., Zhang, T., Yu, J., Cheng, M. H., Wu, Y., Cheng, J., & Ma, W. (2019) · Biomaterials Science · doi:10.1039/c9bm00214f · Cited by 43
Investigation of Nanostructured Lipid Carriers for Transdermal Delivery of Flurbiprofen
Han, F., Li, S., Yin, R., et al. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040701833708 · Cited by 41
Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer
Engel, J. B., Tinneberg, H., Rick, F. G., et al. (2016) · Current Drug Targets · doi:10.2174/138945011705160303154717 · Cited by 41
Temperature-Tunable Iron Oxide Nanoparticles for Remote-Controlled Drug Release
Dani, R. K., Schumann, C., Taratula, O. R., & Taratula, O. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0131-x · Cited by 39
Self-citationPoly(propyleneimine) dendrimers as potential siRNA delivery nanocarrier: from structure to function
Taratula, O., Savla, R., He, H., & Minko, T. (2010) · International Journal of Nanotechnology · doi:10.1504/ijnt.2011.037169 · Cited by 39
Self-citationWei, Y., Du, Q., Jiang, X., Li, L., Li, T., Li, M., Fan, X., Li, Y., Kariminia, S., & Li, Q. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.04.008 · Cited by 39
Cited by
Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis
Das, S. S., Bharadwaj, P., Bilal, M., Barani, M., Rahdar, A., Taboada, P., Bungau, S., & Kyzas, G. Z. (2020) · Polymers · doi:10.3390/polym12061397 · Cited by 581
Alshawwa, S. Z., Kassem, A. A., Farid, R. M., Mostafa, S. K., & Labib, G. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040883 · Cited by 531
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19
Majumder, J., & Minko, T. (2021) · The AAPS Journal · doi:10.1208/s12248-020-00532-2 · Cited by 505
Self-citationNanoparticles in Drug Delivery: From History to Therapeutic Applications
Afzal, O., Altamimi, A. S. A., Nadeem, M. S., Alzarea, S. I., Almalki, W. H., Tariq, A., Mubeen, B., Murtaza, B. N., Iftikhar, S., Riaz, N., et al. (2022) · Nanomaterials · doi:10.3390/nano12244494 · Cited by 468
Recent progress in nanomedicine for enhanced cancer chemotherapy
Wei, G., Wang, Y., Yang, G., Wang, Y., & Ju, R. (2021) · Theranostics · doi:10.7150/thno.57828 · Cited by 463
Metadata
- Authors
- Majumder, J., Taratula, O., & Minko, T.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 144
- Pages
- 57-77
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2966612446
- Cited by
- 394
- References
- 221
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.